Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab

Completed · Phase 1

Conditions studied: Plasma Concentrations

In brief

Determine the plasma concentration profile after single and multiple dosing of Sufentanil NanoTabs

Key facts

Study ID

NCT01761565

Run by

Talphera, Inc

People needed

40

Starts

2013-01-01

Expected to finish

2013-02-01

Last updated by the study team

2015-10-01

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Non smoking
• Ages 18 to 45 year, inclusive
• BMI between 18 and 30

You may not qualify if…

• Subjects taking any prescription or OTC medications or vitamins or supplements
• Pregnant females
• Subjects with pulmonary disease or sleep apnea

Where it is running

• PRA — Lenexa, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.